Tag Archives: Foundation Medicine

A Director at Foundation Medicine (NASDAQ: FMI) is Selling Shares

Today, a Director at Foundation Medicine (NASDAQ: FMI), Michael Pellini, sold shares of FMI for $1.77M. Following Michael Pellini’s last FMI Sell transaction on August 10, 2017, the stock climbed by 19.6%. In addition to Michael Pellini, 4 other FMI

The CMO of Foundation Medicine (NASDAQ: FMI) is Selling Shares

Today, the CMO of Foundation Medicine (NASDAQ: FMI), Vincent Miller, sold shares of FMI for $1.22M. In addition to Vincent Miller, 4 other FMI executives reported Sell trades in the last month. Based on Foundation Medicine’s latest earnings report for

The CFO of Foundation Medicine is Exercising Options

Today, the CFO of Foundation Medicine, Jason Ryan, exercised options of Foundation Medicine for $1.33M. Following Jason Ryan’s last FMI Sell transaction on March 20, 2017, the stock climbed by 25.8%. In addition to Jason Ryan, 4 other FMI executives

The SVP and General Counsel of Foundation Medicine (NASDAQ: FMI) is Selling Shares

Today, the SVP and General Counsel of Foundation Medicine (NASDAQ: FMI), Robert Hesslein, sold shares of FMI for $197.3K. Following Robert Hesslein’s last FMI Sell transaction on January 05, 2017, the stock climbed by 14.2%. In addition to Robert Hesslein,

Analysts Have Conflicting Sentiments on These Healthcare Companies: Foundation Medicine Inc (NASDAQ: FMI) and Pfizer Inc (NYSE: PFE)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Foundation Medicine Inc (NASDAQ: FMI) and Pfizer Inc (NYSE: PFE). Foundation Medicine Inc (NASDAQ: FMI) UBS analyst Jon Groberg reiterated a Hold rating on Foundation

BTIG Reiterates a Hold Rating on Foundation Medicine

According to The Fly, in a report released yesterday, Karen Koski from BTIG reiterated a Hold rating on Foundation Medicine (NASDAQ: FMI). The company’s shares closed yesterday at $24.18, close to its 52-week high of $25.98. According to TipRanks.com, Koski